233 related articles for article (PubMed ID: 16445781)
1. The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodesiccation.
de Graaf YG; Basdew VR; van Zwan-Kralt N; Willemze R; Bavinck JN
Br J Dermatol; 2006 Mar; 154(3):493-7. PubMed ID: 16445781
[TBL] [Abstract][Full Text] [Related]
2. Five-year results of curettage-cryosurgery for 100 consecutive auricular non-melanoma skin cancers.
Nordin P; Stenquist B
J Laryngol Otol; 2002 Nov; 116(11):893-8. PubMed ID: 12487665
[TBL] [Abstract][Full Text] [Related]
3. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.
Harwood CA; Leedham-Green M; Leigh IM; Proby CM
Arch Dermatol; 2005 Apr; 141(4):456-64. PubMed ID: 15837863
[TBL] [Abstract][Full Text] [Related]
4. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
[TBL] [Abstract][Full Text] [Related]
5. Controversies in skin surgery: electrodessication and curettage versus excision for low-risk, small, well-differentiated squamous cell carcinomas.
Reschly MJ; Shenefelt PD
J Drugs Dermatol; 2010 Jul; 9(7):773-6. PubMed ID: 20677531
[TBL] [Abstract][Full Text] [Related]
6. Curettage-electrodesiccation treatment of basal cell carcinomas.
Kopf AW; Bart RS; Schrager D; Lazar M; Popkin GL
Arch Dermatol; 1977 Apr; 113(4):439-43. PubMed ID: 848972
[TBL] [Abstract][Full Text] [Related]
7. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience.
Veness MJ; Quinn DI; Ong CS; Keogh AM; Macdonald PS; Cooper SG; Morgan GW
Cancer; 1999 Apr; 85(8):1758-64. PubMed ID: 10223570
[TBL] [Abstract][Full Text] [Related]
8. Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases.
Chaux A; Reuter V; Lezcano C; Velazquez EF; Torres J; Cubilla AL
Am J Surg Pathol; 2009 Sep; 33(9):1299-306. PubMed ID: 19471153
[TBL] [Abstract][Full Text] [Related]
9. Proliferation characteristics of cutaneous squamous cell carcinomas developing in organ graft recipients. Comparison with squamous cell carcinomas of nonimmunocompromised hosts by counting argyrophilic proteins associated with nucleolar organizer regions.
Hoyo E; Kanitakis J; Euvrard S; Thivolet J
Arch Dermatol; 1993 Mar; 129(3):324-7. PubMed ID: 8447668
[TBL] [Abstract][Full Text] [Related]
10. Nonmelanoma skin cancers and infection with the human immunodeficiency virus.
Lobo DV; Chu P; Grekin RC; Berger TG
Arch Dermatol; 1992 May; 128(5):623-7. PubMed ID: 1575523
[TBL] [Abstract][Full Text] [Related]
11. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients.
Carucci JA; Martinez JC; Zeitouni NC; Christenson L; Coldiron B; Zweibel S; Otley CC
Dermatol Surg; 2004 Apr; 30(4 Pt 2):651-5. PubMed ID: 15061850
[TBL] [Abstract][Full Text] [Related]
12. Clinical and histological findings in re-excision of incompletely excised cutaneous squamous cell carcinoma.
Bovill ES; Cullen KW; Barrett W; Banwell PE
J Plast Reconstr Aesthet Surg; 2009 Apr; 62(4):457-61. PubMed ID: 18218349
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort with regard to tumor site.
Lindelöf B; Dal H; Wolk K; Malmborg N
Arch Dermatol; 2005 Apr; 141(4):447-51. PubMed ID: 15837862
[TBL] [Abstract][Full Text] [Related]
14. Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy.
Willey A; Mehta S; Lee PK
Dermatol Surg; 2010 May; 36(5):652-8. PubMed ID: 19889154
[TBL] [Abstract][Full Text] [Related]
15. Prospective trial of curettage and cryosurgery in the management of non-facial, superficial, and minimally invasive basal and squamous cell carcinoma.
Peikert JM
Int J Dermatol; 2011 Sep; 50(9):1135-8. PubMed ID: 22126880
[TBL] [Abstract][Full Text] [Related]
16. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
[TBL] [Abstract][Full Text] [Related]
17. Mortality and clinicopathological features of cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort.
Lindelöf B; Jarnvik J; Ternesten-Bratel A; Granath F; Hedblad MA
Acta Derm Venereol; 2006; 86(3):219-22. PubMed ID: 16710578
[TBL] [Abstract][Full Text] [Related]
18. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
[TBL] [Abstract][Full Text] [Related]
19. Failure of curettage and electrodesiccation for removal of basal cell carcinoma.
Suhge d'Aubermont PC; Bennett RG
Arch Dermatol; 1984 Nov; 120(11):1456-60. PubMed ID: 6497413
[TBL] [Abstract][Full Text] [Related]
20. Multivariate risk score for recurrence of cutaneous basal cell carcinomas.
Dubin N; Kopf AW
Arch Dermatol; 1983 May; 119(5):373-7. PubMed ID: 6847215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
